Cargando…

Serum osteoprotegerin in prevalent hemodialysis patients: associations with mortality, atherosclerosis and cardiac function

BACKGROUND: To assess whether serum osteoprotegerin (OPG) and/or fetuin-A predict mortality and cardiovascular (CV) morbidity and mortality in hemodialysis patients. METHODS: Multicenter, observational, prospective study that included 220 hemodialysis patients followed up for up to 6 years. Serum OP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collado, Sílvia, Coll, Elisabeth, Nicolau, Carlos, Azqueta, Manel, Pons, Mercedes, Cruzado, Josep M, de la Torre, Bernat, Deulofeu, Ramón, Mojal, Sergi, Pascual, Julio, Cases, Aleix
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590161/ https://www.ncbi.nlm.nih.gov/pubmed/28882110 http://dx.doi.org/10.1186/s12882-017-0701-8

Ejemplares similares

Carotid Atherosclerotic Disease Predicts Cardiovascular Events in Hemodialysis Patients: A Prospective Study
por: Collado, Sílvia, et al.
Publicado: (2015)

Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients
por: Pateinakis, Panagiotis, et al.
Publicado: (2013)

Serum osteoprotegerin level in hemodialysis patients using low‐flux reused dialyzer in relation to atherosclerosis
por: Do Van, Tung, et al.
Publicado: (2021)

A biomarker, osteoprotegerin, in patients undergoing hemodialysis
por: Ko, Gang Jee
Publicado: (2013)

Osteoprotegerin as a Marker of Atherosclerosis in Diabetic Patients
por: Augoulea, Areti, et al.
Publicado: (2013)

Relationship between serum osteoprotegerin and vascular calcifications in hemodialysis patients
por: El Baz, Tarek Z., et al.
Publicado: (2017)

Osteoprotegerin Gene Polymorphisms Are Associated with Subclinical Atherosclerosis in the Mexican Mestizo Population
por: Cazarín-Santos, Benny Giovanni, et al.
Publicado: (2022)

Early Atherosclerosis in HIV Infected Subjects on Suppressive Antiretroviral Treatment: Role of Osteoprotegerin
por: D'Abramo, Alessandra, et al.
Publicado: (2013)

Serum osteoprotegerin is associated with vascular stiffness and the onset of new cardiovascular events in hemodialysis patients
por: Lee, Jung Eun, et al.
Publicado: (2013)

Immune Activation, Immunosenescence, and Osteoprotegerin as Markers of Endothelial Dysfunction in Subclinical HIV-Associated Atherosclerosis
por: D'Abramo, Alessandra, et al.
Publicado: (2014)

Prediabetes Is Independently Associated with Subclinical Carotid Atherosclerosis: An Observational Study in a Non-Urban Mediterranean Population
por: Vilanova, Maria Belén, et al.
Publicado: (2020)

Serum Osteoprotegerin Level Is Negatively Associated with Bone Mineral Density in Patients Undergoing Maintenance Hemodialysis
por: Lu, Chia-Wen, et al.
Publicado: (2021)

Endothelial Damage, Inflammation and Immunity in Chronic Kidney Disease
por: Diaz-Ricart, Maribel, et al.
Publicado: (2020)

Osteoprotegerin and MTHFR gene variations in rheumatoid arthritis: association with disease susceptibility and markers of subclinical atherosclerosis
por: Arida, Aikaterini, et al.
Publicado: (2022)

Therapeutic implications of osteoprotegerin
por: Fili, Sofia, et al.
Publicado: (2009)

The role of osteoprotegerin in arthritis
por: Schett, Georg, et al.
Publicado: (2003)

Osteoprotegerin in Cardiometabolic Disorders
por: Pérez de Ciriza, C., et al.
Publicado: (2015)

Unveiling ncRNA regulatory axes in atherosclerosis progression
por: Navarro, Estanislao, et al.
Publicado: (2020)

Features of atherosclerosis in hemodialysis patients
por: Park, Kyong Ah, et al.
Publicado: (2013)

Expression of osteoprotegerin and osteoprotegerin ligand in giant cell tumor of bone and its clinical significance
por: YU, XIUCHUN, et al.
Publicado: (2013)

Datasets for the validation of the "in vivo" siRNA-silencing of CD40 and for the detection of new markers of atherosclerosis progression in ApoE-deficient mice
por: Hueso, Miguel, et al.
Publicado: (2016)

Biology of RANK, RANKL, and osteoprotegerin
por: Boyce, Brendan F, et al.
Publicado: (2007)

An Exonic Switch Regulates Differential Accession of microRNAs to the Cd34 Transcript in Atherosclerosis Progression
por: Hueso, Miguel, et al.
Publicado: (2019)

ALUminating the Path of Atherosclerosis Progression: Chaos Theory Suggests a Role for Alu Repeats in the Development of Atherosclerotic Vascular Disease
por: Hueso, Miguel, et al.
Publicado: (2018)

Osteoprotegerin induction in response to microbial infection
por: Takada, Yasunari, et al.
Publicado: (2012)

Expression and Regulation of Osteoprotegerin in Adipose Tissue
por: An, Juan-Ji, et al.
Publicado: (2007)

A Variant in the Osteoprotegerin Gene Is Associated with Coronary Atherosclerosis in Patients with Rheumatoid Arthritis: Results from a Candidate Gene Study
por: Chung, Cecilia P., et al.
Publicado: (2015)

Management of the SARS-CoV-2 (COVID-19) coronavirus epidemic in hemodialysis units()
por: Arenas, María Dolores, et al.
Publicado: (2020)

Basophil Activation Test identifies the patients with Chronic Spontaneous Urticaria suffering the most active disease
por: Curto‐Barredo, Laia, et al.
Publicado: (2016)

Prediction scores for risk of allograft loss in patients receiving kidney transplants: nil satis nisi optimum
por: Montero, Nuria, et al.
Publicado: (2020)

Osteoprotegerin, Soluble Receptor Activator of Nuclear Factor-κB Ligand, and Subclinical Atherosclerosis in Children and Adolescents with Type 1 Diabetes Mellitus
por: Lambrinoudaki, Irene, et al.
Publicado: (2013)

Elevated levels of plasma osteoprotegerin are associated with all-cause mortality risk and atherosclerosis in patients with stages 3 to 5 chronic kidney disease
por: Nascimento, M.M., et al.
Publicado: (2014)

Aortic flow propagation velocity, epicardial fat thickness, and osteoprotegerin level to predict subclinical atherosclerosis in patients with nonalcoholic fatty liver disease
por: Oğuz, Didem, et al.
Publicado: (2016)

Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients
por: Sans, Laia, et al.
Publicado: (2016)

Chronic kidney disease in the type 2 diabetic patients: prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area
por: Coll-de-Tuero, Gabriel, et al.
Publicado: (2012)

Up‐regulation of HDACs, a harbinger of uraemic endothelial dysfunction, is prevented by defibrotide
por: Palomo, Marta, et al.
Publicado: (2019)

RANK, RANKL and osteoprotegerin in bone biology and disease
por: Wright, H. L., et al.
Publicado: (2009)

Osteoprotegerin and Mortality in Type 2 Diabetic Patients
por: Reinhard, Henrik, et al.
Publicado: (2010)

Expression of Osteoprotegerin in Placenta and Its Association with Preeclampsia
por: Shen, Pei, et al.
Publicado: (2012)

Gingival crevicularfluid osteoprotegerin levels in Indian population
por: Bandari, Purnima, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_21ucf4vlh316uaev2en6mavqau